Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-20

Clinical Trial Update: Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating photoactive porphyrin (PAP) levels after topical application of Visonac in acne patients; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Visonac

Snippet

Sponsor: Photocure | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2014-05-20